Sandoz

Global Senior Solution Engineer - SAP ABAP/FIORI

Sandoz
Apply
13 hours ago
Prague, Czechia or Hyderābād, IndiaSenior

Responsibilities

  • Design, develop, and govern SAP ABAP development standards, including OO ABAP, CDS Views, AMDP, enhancements, BAdIs, and user exits.
  • Design and develop SAP Fiori applications using SAPUI5 and Fiori Elements, including extensions to standard applications and custom applications.
  • Review and optimize data models, interfaces, database usage, and HANA-optimized development for performance.
  • Develop and use OData services and SAP Gateway for frontend-backend integration.
  • Support integration with SAP and non-SAP systems and ensure alignment with SAP best practices and enterprise standards.
  • Translate business requirements into technical specifications and solution designs in collaboration with functional teams and architects.
  • Analyze and resolve incidents related to ABAP and Fiori applications.
  • Allocate tasks, manage supplier-team workload, mentor team members, and lead complex technical developments and problem resolution.

Requirements

  • At least 10 years of ABAP programming experience, including OO ABAP, CDS, and debugging.
  • Strong hands-on experience in SAP ABAP development and SAP Fiori/UI5 development.
  • Knowledge of OData services and SAP Gateway.
  • Experience in S/4HANA environments is preferred.
  • Knowledge of SAP BTP is required.
  • Understanding of SAP modules such as FI, SD, MM, and BW is a plus.
  • Bachelor’s or master’s degree in computer science, IT, or a related field.
  • Fluent written and spoken English is required.
  • Analytical, problem-solving, communication, collaboration, quality, and performance-focused skills.

Tech Stack

ABAP

Categories

Sandoz

About Sandoz

10,000+ employees

Sandoz develops, manufactures, and markets generic medicines, biosimilars, and over-the-counter products for patients, health systems, and pharmacies worldwide. Headquartered in Basel, Switzerland, it became an independent, publicly traded company in 2023 following a spin-off from Novartis and is listed on the SIX Swiss Exchange. Its portfolio spans many therapeutic areas and is supplied to more than 100 countries through hospital, retail, and tender channels.

Contact me